Amplify Weight Loss Drug & Treatment ETF Rating $22.75 -0.11 (-0.48%) As of 07/18/2025 04:10 PM Eastern Add Compare Share Share Ratings Stock AnalysisChartHoldingsOwnershipRatingsShort InterestBuy This Stock Amplify Weight Loss Drug & Treatment ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.THNR Aggregate RatingModerate Buy 2.57Holdings in THNR have an aggregate rating of Moderate Buy based on 187 analyst ratings issued in the past year covering 14 companies (70.0% of the portfolio).THNR Aggregate Price Target$22.75High Prediction$22.75Average Prediction$22.75Low Prediction$22.75Holdings in THNR have an aggregate price target of $22.75 and a range of $22.75 to $22.75 covering 14 companies (70.0% of the portfolio).THNR Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy4 Buy rating(s)Moderate Buy5 Moderate Buy rating(s)Hold4 Hold rating(s)Reduce1 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Amplify Weight Loss Drug & Treatment ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 14 THNR Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings14.05%NVONovo Nordisk A/S$64.32-1.5%4.2332 of 5 stars2.27$112.00 74.1%11Positive News13.77%LLYEli Lilly and Company$771.78+1.3%4.9755 of 5 stars2.75$1,012.56 31.2%20Trending News7.61%HIMSHims & Hers Health$50.36+0.7%2.5299 of 5 stars1.92$39.83 -20.9%13Trending NewsAnalyst ForecastInsider Trade4.96%TEVATeva Pharmaceutical Industries$16.08-1.4%4.238 of 5 stars3.25$24.71 53.7%8News CoverageAnalyst Downgrade4.65%WSTWest Pharmaceutical Services$210.91-4.8%4.7815 of 5 stars2.89$320.00 51.7%9Upcoming Earnings4.52%PFEPfizer$24.46-0.5%4.9717 of 5 stars2.45$28.55 16.7%22Trending News4.46%AMGNAmgen$294.76-1.2%4.3942 of 5 stars2.35$307.82 4.4%23Trending NewsAnalyst Revision4.42%AZNAstraZeneca$68.79-0.7%4.0477 of 5 stars2.83$89.00 29.4%6Trending NewsAnalyst Revision4.03%MRKMerck & Co., Inc.$79.97-1.9%4.9954 of 5 stars2.43$108.69 35.9%21Positive NewsAnalyst Revision3.82%TMOThermo Fisher Scientific$415.29-2.3%4.9939 of 5 stars2.80$599.30 44.3%20Trending NewsUpcoming EarningsAnalyst ForecastAnalyst Revision1.81%GPCRStructure Therapeutics$19.25-1.4%2.9635 of 5 stars3.00$76.17 295.7%7Positive NewsHigh Trading Volume1.44%VKTXViking Therapeutics$32.01-0.2%4.6052 of 5 stars3.00$87.15 172.3%14Positive NewsUpcoming Earnings0.27%ALTAltimmune$4.08+0.7%2.2095 of 5 stars2.75$18.20 346.1%80.20%OPKOPKO Health$1.35-2.2%3.599 of 5 stars3.00$2.75 103.7%5 This page (NYSEARCA:THNR) was last updated on 7/20/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredTurn $1K into $50K with This DeFi GemTHREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredBuffett to put 90% of his money in this one stock?CPA and CFA says you have WAY too many stocks - just buy these 3 After years working at the biggest accoun...Altimetry | SponsoredThis Could Be the Most Profitable Season of Your LifeInstitutional money is pouring in. Bitcoin ETFs are live. Altcoin adoption is accelerating. This is the sam...Crypto Swap Profits | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredI was wrong about TrumpI made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Amplify Weight Loss Drug & Treatment ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Amplify Weight Loss Drug & Treatment ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free THNR Stock Alerts